Advertisement

Abstract

The fact that the father of both hemodialysis [1] and plasmapheresis [2] is one and the same, and that he proposed both forms of therapy in the same year, provides an historical link between the two modes of treatment. The advent of on line centrifugation systems for apheresis in the mid-fifties, however, moved this new technique into the domain of hematologists. Plasma donation procedures have improved immensely in recent years. They are usually performed by blood banks and as such will not be considered here. This survey will deal only with therapeutic apheresis, which nowadays is practiced both by hematologists and nephrologists, and has become an integral part of the training programs in both disciplines.

Keywords

Systemic Lupus Erythematosus Lupus Nephritis Plasma Exchange Thrombotic Thrombocytopenic Purpura Dextran Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abel, J.J., Rowntree, L.G., and Turner, B.B., 1914, On the removal of diffuse substances from the circulating blood of living animals by dialysis, J. Pharmacol. Exp. Ther., 5:275.Google Scholar
  2. 2.
    Abel, J.J., Rowntree, L.G., and Turner, B.B., 1914, Plasma removal with return of corpuscles (plasmapheresis), J. Pharmacol. Exp. Ther., 5:625.Google Scholar
  3. 3.
    Report of the AMA panel on therapeutic plasmapheresis. Current status of therapeutic plasmapheresis and related techniques, 1985, J. Am. med. Ass., 253:819.Google Scholar
  4. 4.
    Klein, H.G., Balow, J.E., Dau, P.C., Hamburger, M.I., Leitman, S.F., Pineda, A.A., and Tindall, R.S.A., 1986, Clinical applications of therapeutic apheresis, J. clin. Apheresis, 3:1.CrossRefGoogle Scholar
  5. 5.
    The NIH consensus development conference on plasmapheresis in neurological diseases, 1986.Google Scholar
  6. 6.
    Rock, G., Tricklebank, G., and Members of the Canadian Apheresis Study Group, 1988, Five years of therapeutic plasma exchange in Canada, 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  7. 7.
    Dau, P. and Khatri, B.O., 1988, Double-blind study of true vs. sham plasma exchange in patients being treated with immunosuppression for acute attacks of multiple sclerosis, 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  8. 8.
    Schmitt, E. and Behm, E., 1988, Immunoadsorption vs. plasma exchange in multiple sclerosis, 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  9. 9.
    Khatri, B.O., 1988, Plasma exchange combined with immunosuppressive drug therapy in chronic progressive multiple sclerosis, 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  10. 10.
    Jayne, D.R.W, Marshall, P.D., Jones, S.J., and Lockwood, C.M., Prospective study of anti-glomerular basement membrane and anti-neutrophil cytoplasm autoantibodies in patients with a putative diagnosis of rapidly progressive glomerulonephritis and description of a subgroup with dual autoantibody positivity, Submitted for publication.Google Scholar
  11. 11.
    Clough, J., Lewis, E., Lachin, J., and the Lupus Nephritis Collaborative Study Group, 1988, A controlled trial of plasmapheresis as adjunct to conventional therapy in severe lupus nephritis. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  12. 12.
    Austin, H.A., Klippel, J.H., and Balow, J.E., 1988, Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs, New Engl. J. Med., 318:1423.CrossRefGoogle Scholar
  13. 13.
    McCune, W.J., Golbus, J., Zelders, W., Bohlke, P., Dunne, R., and Fox, D.A., 1988, Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe lupus erythematosus, New Engl. J. Med., 318:1423.PubMedCrossRefGoogle Scholar
  14. 14.
    Euler, H.H., Schroeder, J.O., Harten, P., and Löffler, H., 1988, Synchronization of plasma exchange with subsequent pulse cyclophosphamide: Induction of stable remissions in severe SLE. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  15. 15.
    Kaplan, A.A. and Halley, S.E., 1988, Evaluation of a rotating filter for use with therapeutic plasma exchange. 34th Annual Meeting of the American Society for Artificial Internal Organs, Reno (USA), May 3–6, 1988.Google Scholar
  16. 16.
    Klein, J., Catapano, G., Feldhoff, P., Bunke, C., and Klein. E., 1988, Small volume therapeutic pheresis as an alternative to conventional pheresis. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  17. 17.
    Gunzer, U., Klinker, E., Klink, M., Mansouri-Taleghani, B., and Günther,C., 1988, Repeated small volume plasmapheresis in patients with immunthrombopenia. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  18. 18.
    Agishi, T., Kaneko, I., and Hasuo, Y., 1980, Double filtratin plasmapheresis with no or minimal amount of blood derivate for substitution, in; Plasma exchange. Plasmapheresis — plasmaseparation, H.–G. Sieberth, ed., Schattauer, New York, p. 53–57.Google Scholar
  19. 19.
    Antiwiler, G.D., Dau, P.C., and Lobdell, D.D., 1988, Reduction of lowdensity lipoproteins with dextran sulfate in patients with familial hypercholesterolemia, J. clin. Apheresis, 4:18.CrossRefGoogle Scholar
  20. 20.
    Seidel, D., Schuff-Werner, P., Eisenhauer, Th., Armstrong, V.W., Janning, G., Thiery, J., and Scheler, F., 1988, Long-term experience with HELP system for the treatment of severe hypercholesterolemia. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  21. 21.
    Lupien, P.J. and Moorjani, S., 1976, A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography, Lancet, I:1261.CrossRefGoogle Scholar
  22. 22.
    Snyder, H.W. Jr., Bertram, J., and Kiprov, D., Extracorporeal immunoadsorption of plasma over PROSORBA Columns as treatment for idiopathic thrombocytopenic purpura in HTLV-III infected homosexual men, In press.Google Scholar
  23. 23.
    Messerschmidt, G.L., Henry, D.H., and Snyder, H.W., 1988, Protein A immunoadsorption in the treatment of malignant disease, J. clin. Oncology, 6:203.Google Scholar
  24. 24.
    Nilsson, I.M., Freiburghaus, C., Sundquist, S.B., and Sandberg, H., 1984, Removal of specific antibodies from whole blood in a continuous extracorporeal system. Plasma Ther. Transfus. Technol., 5:127.Google Scholar
  25. 25.
    Palmer, A., Taube, D., and Welsh, K., 1987, Extracorporeal immunoadsorption of anti-HLA antibodies: Preliminary clinical experience. Transplant. Proc, XIX(5):3750.Google Scholar
  26. 26.
    Heininger, K., Toyka, K.V., Gaczkowski, A., Hartung, H.P., Borberg, H., and Grabensee, B., 1986, Selective removal of pathogenic factors in neurologic diseases. Plasma Ther. Transfus. Technol., 7:351.Google Scholar
  27. 27.
    Heininger, K., Gaczkowski, A., Hartung, H.P., Toyka, K.V., and Borberg, H., 1986, Plasma separation and immunoadsorption in myasthenia gravis, in: Therapeutic plasmapheresis (V), T. Oda, ed., Schattauer, Stuttgart-New York, p. 3–10.Google Scholar
  28. 28.
    Behm, E., Loth, F., and Toewe, D., 1988, A newly developed LDL-binding material. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  29. 29.
    Busnach, G., Cappelleri, A., and Vaccarino, V., 1988, Selective and semiselective low-density lipoprotein apheresis in familial hypercholesterolemai, Blood Purification, 6:161.CrossRefGoogle Scholar
  30. 30.
    Mimori, A., Takahashi, K., and Mitamura, T., 1987, Clinical evaluation of the three types of plasmapheresis in a patient with type IIa familial hypercholesterolemia, 1987, J. clin. Apheresis, 3:209.PubMedCrossRefGoogle Scholar
  31. 31.
    Kinoshita, M., Ishikawa, H., Aotsuka, S., Yokohari, R., Funahashi, T., and Tani, N., 1988, Selective adsorption on anti-dsDNA antibodies by dextran sulfate. 2nd International Congress of the World Apheresis Association, Ottawa, CDN, May 18–20, 1988.Google Scholar
  32. 32.
    Bosch, T., Schmidt, B., Samtleben, W., and Gurland, H.J., 1987, A new LDL-adsorption column: Ex vivo clinical performance and biocompatibility, in: Proceedings of the 1st International Congress of the World Apheresis Association, T. Oda, Y. Shiokawa, N. Inoue, eds., ISAO Press, Cleveland, p. 576–580.Google Scholar
  33. 33.
    Heald, P.W., 1988, Extracorporeal photochemotherapy for CTCL. 2nd International Congress of the World Apheresis Association, Ottawa (CDN), May 18–20, 1988.Google Scholar
  34. 34.
    Böck, M., Krause, Ch., and Wagner, M., 1987, Transfusion of leukocyte depleted red cell concentrates and whole blood by use of a newly developed “bed-side” filter system. 5th Annual Meeting of the European Society for Haemapheresis, Cologne (FRG), September 20–23, 1987.Google Scholar
  35. 35.
    Kemshead, J.T. Heath, L., and Gibson, F.M., 1986, Magnetic microspheres and monoclonal antibodies for the depletion of neuroplastoma cells from bone marrow: Experiences, improvements and observations, Br. J. Cancer, 54:771.PubMedCrossRefGoogle Scholar
  36. 36.
    Rosenberg, S.A., Lotze,M.T., and Muul, L.M., 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokineactivated killer cells and interleukin-2 or high dose interleukin-2 alone, New Engl. J. Med., 316:879.CrossRefGoogle Scholar
  37. 37.
    Brandt, S., Peters, W.P., and Atwater, S.K., 1988, Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation, New Engl. J. Med., 318:869.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Hans J. Gurland
    • 1
  1. 1.Nephrology DepartmentUniversity Hospital Munich GrosshadernMunich 70Germany

Personalised recommendations